Search results
Results From The WOW.Com Content Network
In addition to Helicobacter pylori research, the Centre conducted varied research into infectious disease identification and surveillance, diagnostics and drug design, and transformative discovery. His research group expanded to embrace new technologies, including Next-Generation Sequencing and genomic analysis.
Synergyst Research launched a spin-off company, Discovery Clinical Trials, in 2009. The company helps Synergyst clients develop and manage new research departments. [ 1 ] In November 2012 the two companies combined were named for a second year in a row on the 5000 List of "America's Fastest-Growing Private Companies," ranking No. 145 among ...
Karl Landsteiner ForMemRS [2] (German: [kaʁl ˈlantˌʃtaɪnɐ]; 14 June 1868 – 26 June 1943 [3]) was an Austrian-American biologist, physician, and immunologist. [4] He emigrated with his family to New York in 1923 at the age of 55 for professional opportunities, working for the Rockefeller Institute.
Horizon Discovery Group plc (LSE: HZD) ("Horizon"), [2] is a gene editing company that designs and engineers genetically modified cells and then applies them in research and clinical applications in human health.
In February 2015, AMRI acquired SSCI based in West Lafayette, Indiana. SSCI was founded in 1991, providing comprehensive cGMP solid state chemistry research and analytical services to the pharmaceutical industry. Servicing more than 250 customers a year. [25] [26] In July 2015, the company acquired Gadea Pharmaceutical group for $174 million. [27]
Dharmacon Inc., now known as Dharmacon, was founded in 1995 by Stephen Scaringe as Dharmacon Research to develop and commercialize a new technology for RNA oligonucleotide synthesis. Originally, the company's focus was to develop 2'-ACE RNA technology as the standard for RNA synthesis and to advance RNA oligo-dependent applications and ...
Discovery science (also known as discovery-based science) is a scientific methodology which aims to find new patterns, correlations, and form hypotheses through the analysis of large-scale experimental data. The term “discovery science” encompasses various fields of study, including basic, translational, and computational science and ...
D. E. Shaw Research (DESRES) is a privately held biochemistry research company based in New York City.Under the scientific direction of David E. Shaw, the group's chief scientist, D. E. Shaw Research develops technologies for molecular dynamics simulations (including Anton, [1] [2] a massively parallel special-purpose supercomputer, and Desmond, [3] a software package for use on conventional ...